You are here

Kamada

Kamada slumps after Shire hands back rights

BioPharma Dive

Thu, 06/8/17 - 10:05 pm

alpha-1 antitrypsin

graft vs host disease

Kamada's rabies treatment clears Phase III with an FDA app on deck

Fierce Biotech

Thu, 12/24/15 - 10:16 am

clinical trials

Baxalta bets again on Kamada with lung transplant deal

Fierce Biotech

Tue, 06/23/15 - 11:22 am

lung transplants

Baxter International

Israeli Biotech New Issues Set A Blistering Pace

Investors.com

Wed, 01/15/14 - 09:06 am

Oramed Pharmaceuticals

Kamada Said to Seek as Much as $50 Million in Nasdaq Listing

Bloomberg

Wed, 01/9/13 - 10:25 pm

Kamada: Wise Strategy or Overly Ambitious?

Seeking Alpha

Mon, 07/12/10 - 10:41 am